Analysis show 2 doses of COVID-19 vaccines highly effective against hospitalisation from Delta variant

Analysis of 14,019 cases of Delta variant, 166 of whom were hospitalised between 12 April and 4 June, suggests Pfizer-BioNTech vaccine is 96% and Oxford-AstraZeneca vaccine is 92% effective against hospitalisation after 2 doses, which is comparable to data for the Alpha variant.

Source:

Public Health England